What is the registration number for ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH?

ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH is registered under USPTO registration number 5410821.

ACT

USPTO Trademark Record

REGISTERED

ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH

Q: Who owns the ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH trademark?

The ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH trademark is owned by Albuquerque Clinical Trials, Inc..

Q: What class is the ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH trademark registered in?

The ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH trademark is registered in Class 042 (Scientific, technology & SaaS services).

Q: What is the serial number for ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH?

The USPTO serial number for ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH is 87414160.

SN 87414160·Reg 5410821·Filed Apr 17, 2017

Owner Albuquerque Clinical Trials, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH (Serial No. 87414160), Registration No. 5410821, is a registered US trademark filed on Apr 17, 2017 by Albuquerque Clinical Trials, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Section 8/9 declaration window: February 28, 2028

Mark Intelligence

ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH (Reg. #5410821) is a registered US trademark that has been protecting its owner, Albuquerque Clinical Trials, Inc., since 2017. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 17, 2017

SERIAL

87414160

REG#

5410821

REGISTERED

Feb 27, 2018

Owner

Applicant

Albuquerque Clinical Trials, Inc.

Entity

Corporation

State

Address

711 Encino Place NE, Albuquerque, NM, 87102

Country

Attorney

Law firm

Albuquerque Clinical Trials, Inc.

Address

711 Encino Place NE, ALBUQUERQUE, NM 87102, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateApr 17, 2017

Serial Number87414160

Registration No.5410821

Registration DateFeb 27, 2018

Status DateMar 19, 2024

Published for OppositionDec 12, 2017

Next RenewalFebruary 28, 2028

Mark TypeDesign with words

Status DescriptionLive and registered, Section 8 accepted

Filing Signals

FILED

2017

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: May 13, 2016

First use in commerce: May 13, 2016

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

26 events

REGISTERED - SEC. 8 (6-YR) ACCEPTED

Mar 19, 2024

REGISTERED - SEC. 8 (6-YR) ACCEPTED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Mar 19, 2024

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Mar 19, 2024

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

TEAS SECTION 8 RECEIVED

Jan 08, 2024

TEAS SECTION 8 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Feb 27, 2023

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Feb 27, 2018

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Dec 12, 2017

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 12, 2017

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 22, 2017

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

LAW OFFICE PUBLICATION REVIEW COMPLETED

Nov 04, 2017

LAW OFFICE PUBLICATION REVIEW COMPLETED

EXAMINER'S AMENDMENT ENTERED

Nov 03, 2017

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 03, 2017

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT E-MAILED

Nov 02, 2017

EXAMINERS AMENDMENT E-MAILED

ASSIGNED TO LIE

Nov 02, 2017

ASSIGNED TO LIE

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Nov 02, 2017

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Nov 02, 2017

EXAMINERS AMENDMENT -WRITTEN

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 31, 2017

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 31, 2017

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 31, 2017

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 19, 2017

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION E-MAILED

Jul 19, 2017

NON-FINAL ACTION E-MAILED

NON-FINAL ACTION WRITTEN

Jul 19, 2017

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Jul 11, 2017

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Apr 25, 2017

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 24, 2017

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Apr 20, 2017

NEW APPLICATION ENTERED

ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Albuquerque Clinical Trials, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Resources

Company